Follow The Filings

Paulson & Co. Inc. John Paulson

Jersey City, NJ 20 processed 13Fs on this site, 2021 Q3 to 2026 Q2

  • $2.6B
  • 8 holdings
  • 2026 Q2
  • −17.2% QoQ
  • Top 5 92.3%

Portfolio

2026 Q2, filed 8/14/2026, 8 holdings

Top 5 92.3%, top 10 100.0%

AUM over time

2026 Q2 $2.6B −17.2% QoQ
2021 Q3: $3.5B 2021 Q3: $3.5B
Q3 2021
2021 Q4: $3.2B, −7.6% QoQ 2021 Q4: $3.2B, −7.6% QoQ
Q4
2022 Q1: $3.2B, +0.2% QoQ 2022 Q1: $3.2B, +0.2% QoQ
Q1 2022
2022 Q2: $2B, −37.6% QoQ 2022 Q2: $2B, −37.6% QoQ
Q2
2022 Q3: $1.4B, −32.6% QoQ 2022 Q3: $1.4B, −32.6% QoQ
Q3
2022 Q4: $1.1B, −18.7% QoQ 2022 Q4: $1.1B, −18.7% QoQ
Q4
2023 Q1: $1.2B, +8.3% QoQ 2023 Q1: $1.2B, +8.3% QoQ
Q1 2023
2023 Q2: $1B, −14.9% QoQ 2023 Q2: $1B, −14.9% QoQ
Q2
2023 Q3: $1.1B, +9.2% QoQ 2023 Q3: $1.1B, +9.2% QoQ
Q3
2023 Q4: $1.1B, −0.9% QoQ 2023 Q4: $1.1B, −0.9% QoQ
Q4
2024 Q1: $1.4B, +30.7% QoQ 2024 Q1: $1.4B, +30.7% QoQ
Q1 2024
2024 Q2: $1.4B, −6.6% QoQ 2024 Q2: $1.4B, −6.6% QoQ
Q2
2024 Q3: $1.4B, +5.3% QoQ 2024 Q3: $1.4B, +5.3% QoQ
Q3
2024 Q4: $1.7B, +15.9% QoQ 2024 Q4: $1.7B, +15.9% QoQ
Q4
2025 Q1: $1.7B, +5.8% QoQ 2025 Q1: $1.7B, +5.8% QoQ
Q1 2025
2025 Q2: $2B, +15.1% QoQ 2025 Q2: $2B, +15.1% QoQ
Q2
2025 Q3: $3B, +47.6% QoQ 2025 Q3: $3B, +47.6% QoQ
Q3
2025 Q4: $3.3B, +9.9% QoQ 2025 Q4: $3.3B, +9.9% QoQ
Q4
2026 Q1: $3.1B, −4.6% QoQ 2026 Q1: $3.1B, −4.6% QoQ
Q1 2026
2026 Q2: $2.6B, −17.2% QoQ 2026 Q2: $2.6B, −17.2% QoQ
Q2

Book

2021 Q3, filed 15 Nov, long equity only

BHC, Bausch Health Companies 20.50% Hold 25,839,035 $27.85 $720M
Horizon Therapeutics Pub 19.25% Hold 6,169,296 $109.54 $676M
AAMI, Brightsphere Investment Group 14.89% Hold 20,000,552 $26.13 $523M
NG, Novagold Resources 4.36% Hold 22,226,300 $6.88 $153M
PPTA, Perpetua Resources 3.51% Hold 24,771,542 $4.98 $123M
OXY, Occidental 3.16% Hold 3,750,000 $29.58 $111M
DIDIY, Didi Global 2.82% Hold 12,703,049 $7.79 $99M
AU, Anglogold Ashanti 2.72% Hold 5,974,331 $15.99 $96M
GOLD, Barrick Gold 2.34% Hold 4,546,771 $18.05 $82M
THRY, Thryv 2.26% Hold 2,636,475 $30.04 $79M
Cloudera 2.09% Hold 4,588,827 $15.97 $73M
Pacira Biosciences 2.01% Hold 1,259,518 $56.00 $71M
XOM, Exxon Mobil 1.89% Hold 1,125,000 $58.82 $66M
APA 1.83% Hold 3,000,000 $21.43 $64M
Endo International 1.60% Hold 17,327,012 $3.24 $56M
Kirkland Lake Gold 1.54% Hold 1,302,853 $41.59 $54M
BALL, Ballys 1.43% Hold 1,000,000 $50.14 $50M
THM 1.31% Hold 61,930,724 $0.7420 $46M
SHEL, Royal Dutch Shell 1.27% Hold 1,000,000 $44.57 $45M
Tim 1.19% Hold 3,900,000 $10.74 $42M
Newmark Group 0.95% Hold 2,323,254 $14.31 $33M
OIH, Vaneck ETF Trust 0.93% Hold 165,000 $197.01 $33M
SA, Seabridge Gold 0.91% Hold 2,070,000 $15.45 $32M
BP, BP PLC 0.78% Hold 1,000,000 $27.33 $27M
Trilogy Metals 0.76% Hold 14,326,996 $1.85 $27M
Pretium Resources 0.66% Hold 2,400,000 $9.64 $23M
TTE, Totalenergies 0.63% Hold 460,000 $47.93 $22M
SSR Mining 0.54% Hold 1,310,242 $14.55 $19M
EQX, Equinox Gold 0.47% Hold 2,500,000 $6.60 $17M
VTRS, Viatris 0.41% Hold 1,055,079 $13.55 $14M
Holding 0.37% Hold 6,300,000 $2.08 $13M
CHCO, Kansas City Southern 0.23% Hold 30,000 $270.63 $8.1M
Iamgold 0.12% Hold 1,850,000 $2.26 $4.2M
BIDU, Baidu 0.09% Hold 20,327 $153.74 $3.1M
BABA, Alibaba 0.08% Hold 17,793 $148.04 $2.6M
Stamps 0.04% Hold 4,068 $329.89 $1.3M

* Reported price is value ÷ shares from the 13F as of period end, not a live market quote. Weight % is each long-equity position ÷ full 13F AUM, so rows may not sum to 100% when the filing includes options or other non-equity (excluded from this table). Click a column header to sort, or New, Hold, Add or Reduce to bring those moves to the top.

Filings history

20 periods, with AUM normalized

Period Holds AUM QoQ Form Filed Filing ID
2026 Q2 8 $2.6B −17.2% 13F-HR 8/14/2026 000101359426000913
2026 Q1 9 $3.1B −4.6% 13F-HR 5/15/2026 000101359426000611
2025 Q4 9 $3.3B +9.9% 13F-HR 2/17/2026 000101359426000257
2025 Q3 10 $3B +47.6% 13F-HR 11/14/2025 000101359425001436
2025 Q2 15 $2B +15.1% 13F-HR 8/14/2025 000101359425001044
2025 Q1 14 $1.7B +5.8% 13F-HR 5/15/2025 000101359425000679
2024 Q4 13 $1.7B +15.9% 13F-HR 2/14/2025 000101359425000309
2024 Q3 15 $1.4B +5.3% 13F-HR 11/14/2024 000101359424000980
2024 Q2 16 $1.4B −6.6% 13F-HR 8/14/2024 000101359424000667
2024 Q1 18 $1.4B +30.7% 13F-HR 5/15/2024 000101359424000487
2023 Q4 17 $1.1B −0.9% 13F-HR 2/14/2024 000101359424000197
2023 Q3 18 $1.1B +9.2% 13F-HR 11/14/2023 000101359423000930
2023 Q2 21 $1B −14.9% 13F-HR 8/14/2023 000101359423000696
2023 Q1 20 $1.2B +8.3% 13F-HR 5/15/2023 000101359423000494
2022 Q4 22 $1.1B −18.7% 13F-HR 2/14/2023 000101359423000262
2022 Q3 28 $1.4B −32.6% 13F-HR 11/14/2022 000156761922020074
2022 Q2 32 $2B −37.6% 13F-HR 8/15/2022 000156761922016238
2022 Q1 33 $3.2B +0.2% 13F-HR 5/16/2022 000156761922011018
2021 Q4 36 $3.2B −7.6% 13F-HR 2/14/2022 000156761922004409
2021 Q3 38 $3.5B — 13F-HR 11/15/2021 000156761921020479

About

Paulson & Co. Inc.

20 processed 13Fs on this site, 2021 Q3 to 2026 Q2

Entity
Paulson & Co. Inc.
Notable person
John Paulson
Location
Jersey City, NJ
All SEC filings
View on sec.gov